Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, clai...

por Smith, B Douglas, Beach, Charles L, Mahmoud, Dalia, Weber, Laura, Henk, Henry J
Publicado em 2014

Correction: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrosp...

por Smith, B Douglas, Beach, Charles L, Mahmoud, Dalia, Weber, Laura, Henk, Henry J
Publicado em 2014

Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine

por Santini, Valeria, Fenaux, Pierre, Mufti, Ghulam J., Hellström-Lindberg, Eva, Silverman, Lewis R., List, Alan, Gore, Steven D., Seymour, John F., Backstrom, Jay, Beach, Charles L.
Publicado em 2010

A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care...

por Gore, Steven D., Fenaux, Pierre, Santini, Valeria, Bennett, John M., Silverman, Lewis R., Seymour, John F., Hellström-Lindberg, Eva, Swern, Arlene S., Beach, Charles. L., List, Alan. F.
Publicado em 2013

Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C

por Fenaux, Pierre, Gattermann, Norbert, Seymour, John F., Hellström-Lindberg, Eva, Mufti, Ghulam J., Duehrsen, Ulrich, Gore, Steven D., Ramos, Fernando, Beyne-Rauzy, Odile, List, Alan, McKenzie, David, Backstrom, Jay, Beach, Charles L.
Publicado em 2010